About
Novavax Inc (NASDAQ:NVAX) — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 30 2026
Novavax Appoints Dr. Robert Walker as Executive Vice President and Head of Research & Development
Mar 13 2026
Nuvaxovid (Novavax) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
Feb 26 2026
Novavax Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights
Feb 19 2026
Novavax to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
Jan 20 2026
Novavax Announces Entering into a License Agreement with Pfizer
Financials
Revenue
$1.12 B
Market Cap
$1.25 B
P/E Ratio
2.98
EPS
2.58
Google Übersetzer